Epidemiological review of the Onchocerciasis in Latin America
DOI:
https://doi.org/10.17533/udea.rfnsp.2428Keywords:
O. volvulus, epidemiology, control programsAbstract
The onchocerciasis is a disease that affects only human beings. It is characterized by itching, skin lesions and ocular damage which can lead to blindness. The endemic areas are limited to zones with optimum latitude, temperature and humidity for the development of the parasite and vector insect. Those zones are found in West Africa, Yemen and some Latin America countries, with Mexico among them. The parasite is transmitted through the bite of a blackfly of the genus Simulium, which inoculates parasite larvae while feeding with blood. The Onchocerciasis Elimination Program of the Americas (OEPA) was created in order to eliminate onchocerciasis as a public health problem. Its strategy is by means of administrating ivermectina and nodulectomy.
Downloads
References
(1). Basañez MG, Pion SD, Churcher TS, Breitling LP, Little MP, Boussinesq M. River blindness: A success story under threat?. PLoS Med 2006;3:1454-1460. DOI: https://doi.org/10.1371/journal.pmed.0030371
(2). Pogonka T, Bradley JE, Titanji VP, Ucius RL. Sensitive and spe-cific serodiagnosis of on onchocerciasis with recombinant hybrid proteins. Am. J. Trop. Med. Hyg 2002;66:566-571. DOI: https://doi.org/10.4269/ajtmh.2002.66.566
(3). Lewallen S, Courtright P. Blindness in Africa: present situation and future needs. Br.J. Ophthalmol 2001;85:897-903. DOI: https://doi.org/10.1136/bjo.85.8.897
(4). Resnikoff S, Pascolini D, Etya’Ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 884-851.
(5). Rodríguez-Pérez MA, Rodríguez-López MH. Enfermedades Tropicales de México, Diagnóstico, Tratamiento y Distribución Geográfica. México. Edit. Instituto Nacional de Diagnóstico y Referencia Epidemiológica 1994;325-333.
(6). Murdoch ME, MC Asuzu, M Hagan, WH Makunde, P Ngoumou, KF Ogbuagu, D Okello, G Ozoh and J Remme. Onchocerciasis: the clinical and epidemiological burden or skin disease in Africa. Ann Trop Med Parasitol 2002; 96: 283-296. DOI: https://doi.org/10.1179/000349802125000826
(7). Boatin BA Richards FO. Control of Onchocerciasis. Adv Parasitol 2006;61:349-94. DOI: https://doi.org/10.1016/S0065-308X(05)61009-3
(8). Enk CD. Onchocerciasis-river-blindness. Clin Dermatil 2006; 24:176-180. DOI: https://doi.org/10.1016/j.clindermatol.2005.11.008
(9). Onchocerciasis Elimination Program of the Americas. [Internet]. Disponible en: http://www.oepa.net.
(10). Martin-Tellaeche A, Ramírez-Hernandez JI, SantoS-Preciado J, Méndez-Galván J. Onchocerciasis: changes in transmission in Mexico. Ann Trop Med Parasitol 1998; 92: 117-119. DOI: https://doi.org/10.1080/00034983.1998.11813374
(11). Rodríguez-Pérez MA, Lilley BG, Domínguez-Vázquez A, Segu-ra-Arenas R, C Lizarazo-Ortega, A Mendoza-Herrera, et al. Poly-merase chain reaction monitoring of transmission of Onchocerca volvulus in two endemic states in Mexico. Am J Trop Med Hyg. 2004; 70: 38-45. DOI: https://doi.org/10.4269/ajtmh.2004.70.38
(12). Vachon M. Onchocerciasis in Chiapas, México. Geogr Rev 1993;83:141-149. DOI: https://doi.org/10.2307/215252
(13). Vázquez-Castellanos JL. Cafeticultura e historia social de la on-cocercosis en el Soconusco, estado de Chiapas, México. Salud Pública Mex 1991;33:124-135.
(14). Service MW. Blackflies (Simuliidae) in Medical Entomology. Chapman and Hall. 1996; 83-88.
(15). Barrera JF, López B. Entomología general. El Colegio de la Frontera Sur 1996; 250 págs.
(16). Schulz-Key H, Karma M. Periodic reproduction of Onchocerca volvulus. Parasitol Today 1986;2:284-286. DOI: https://doi.org/10.1016/0169-4758(86)90138-9
(17). Pearlman E, Lass J. Keratitis due to onchocerciasis. Ophthalmol Clin North Am 1994; 7:641-648.
(18). Bogitsh JB, Cheng C. Human Parasitology. Second ed. Acedemic Press.1998 390-391 págs.
(19). Chester PC, Wayne E. Parasitología Clínica. 2ª ed. México. Edi-torial Interamericana. 1998; 399-401.
(20). Koneman EW, Allen SD, Janda WM, PC Scheckenberger, Winn WC. Diagnóstico Microbiologico. Reimp de la Quinta Edición. Editorial Médica Panamericana 2001; 1104 págs.
(21). Duke BOL. Observations and reflections on the immature stages of Onchocerca volvulus in the human host. Ann Trop Med Para-sitol 1991; 85:103-110. DOI: https://doi.org/10.1080/00034983.1991.11812536
(22). Burnham GM. Onchocerciasis in Malawi: Subjective complaints and decreased weight in persons infected with Onchocerca vol-vulus in the Thyolo highlands. Trans R Soc Trop Med Hyg. 1991, 85:497-500. DOI: https://doi.org/10.1016/0035-9203(91)90234-P
(23). Magdi MA. Inmunologic Aspects of the pathogenesis of Human Onchocerciasis. Tesis de Doctorado. Stockholm University 2006;14-17.
(24). Hoerauf A, Büttner DW, Adjei O, Pearlman E. Endosymbiotic Wolbachia bacteria in the worms are targets for a new therapeutic approach. b m j 2003, 326:207-210.
(25). Gillette-Ferguson I, Hise AG, Sun Y, Diaconu E, McGarry HF, Taylor MJ, et al. Wolbachia and Onchocerca volvulus induced keratitis (river blindness) is dependent on myeloid differentiation factor 88. Infect Immun. 2006,74:2442-2445. DOI: https://doi.org/10.1128/IAI.74.4.2442-2445.2006
(26). Murdoch ME, Hay RJ, Mackenzie CD, Williams JF, Ghalib HW, Cousens S, et al. A clinical classification and grading sys-tem of the coetaneous changes in onchocerciasis. Br J Dermatol 1993;129:260-269. DOI: https://doi.org/10.1111/j.1365-2133.1993.tb11844.x
(27). Zimmerman PA, Dadzie KY, Sole G, Remme J, Unnasch T. Oncho-Oncho-cerca volvulus DNA probe classification correlates with epidemio-logic patterns of blindness. J Infect Dis 1992; 165:964-968. DOI: https://doi.org/10.1093/infdis/165.5.964
(28). García-Dihinx VJ, Betrian P, De Juan F, Bouthelier M, Marin-Bravo C, J Reviño. Parasitosis by Onchocerca volvulus. An Esp Pediatr 2001;55:486-487. DOI: https://doi.org/10.1016/S1695-4033(01)77881-2
(29). Okulicz JF, Stibich AS, Elston DM, Scwartz RA. Cutaneous onchocercoma. Int J Dermatol 2004;43:170-172. DOI: https://doi.org/10.1111/j.1365-4632.2004.02279.x
(30). Fuglsang H, Anderson J. The concentration of microfilariae in the skin near the eye as a simple measure of the severity of on-chocerciasis in a community and as an indicator of danger to the eye. Trop Med Parasitol 1977;28:63-67.
(31). Hagan M. Onchocercal dermatitis: clinical impact. Ann Trop Med Parasitol 1998; 92:S85-96. DOI: https://doi.org/10.1080/00034983.1998.11813371
(32). Kipp W, Bamhuhiiga J. Onchodermal skin disease in a hyperendemic onchocerciasis focus in western Uganda. Am J Trop Med Hyg 2002; 67:475-479. DOI: https://doi.org/10.4269/ajtmh.2002.67.475
(33). Bratig NW, Krawitz I, Abakar H, Ertlman RD, Kruppa TK, Mas-saougbodji A. Strong immunoglobulin G isotype antibody response in sowda type onchocerciasis. J Infect Dis 1994; 170:995-1061. DOI: https://doi.org/10.1093/infdis/170.4.955
(34). Ackerman SJ, Kephart GM, Francis H, Awadzi K, Gleich GJ, Ottesen EA. Eosinophil degranulation: an immunologic deter-minant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J Immunol 1990; 144:3961-3969. DOI: https://doi.org/10.4049/jimmunol.144.10.3961
(35). Luang-Hu L. Visión 2020 and Prevention of Blindness: Is it Revelant of Achievable in the Modern Era? Ann. Acad. Med. Sin-gap 2006; 35:215-222. DOI: https://doi.org/10.47102/annals-acadmedsg.V35N3p215
(36). Braun G, McKechnie NM, Connor V, Gilbert CE, Engelbrecht F, Whitworth JA. Immunological crossreactivity between a cloned of Onchocerca volvulus and a component of the retinal pigment epithelium. J Exp Med. 1991;174:169-77. DOI: https://doi.org/10.1084/jem.174.1.169
(37). Hall LR, Pearlman E. Pathogenesis of onchocercal keratitis (River Blindness). Clin. Microbiol. Rev 1999;12:445-453. DOI: https://doi.org/10.1128/CMR.12.3.445
(38). Hoerauf A, Mand S, Adjei O, Autenrieth B, Fleischer B, Büttner DW. Depletion of Wolbachia endobacteria in Onchocerca vol-vulus by doxycycline and microfilaridermia after ivermectina trearment. Lancet 2001;357:1415-1416.
(39). Egbert PR, Jacobson DW, Fiadovor S, Dadzie P, Ellingson K. Onchocerciasis: a potential risk factor for glaucoma. Br. J.Ophthalmol 2005;89:796-798. DOI: https://doi.org/10.1136/bjo.2004.061895
(40). Soboslay PT, Geiger SM, Weiss N, Banla M, Lauder CG, Dreweck CM, et al. Immunol 1997; 90:592-599. DOI: https://doi.org/10.1046/j.1365-2567.1997.00210.x
(41). Victoria J. Uso de ivermetina en niños. Dermatol Pediatr Lat 2003; 1:61-65.
(42). Hoerauf A, Büttner DW, Adjei O, Pearlman E. Onchocerciasis. b m j 2003; 326: 207-210. DOI: https://doi.org/10.1136/bmj.326.7382.207
(43). Onwujekwe OE, Shun EN, Ndum CC, Okonkwo PO. Treatment with ivermectina: shat works in one community may not work in another. J Epidemiol Community Health 2000 54:79-80. DOI: https://doi.org/10.1136/jech.54.1.79
(44). Etya’ alé D. Eliminating onchocerciasis as a public health problem the beginning of the end. Br J Ophthalmol 2002;86:844-846. DOI: https://doi.org/10.1136/bjo.86.8.844
(45). Blanks J, Richards F, Beltrán F, Collins R, Álvarez E, Zea G, et al. The Onchocerciasis Elimination Program for the Americas: a history of partnership. Pan Am J Public Health 1998;3:367-374. DOI: https://doi.org/10.1590/S1020-49891998000600002
(46). Cupp EW, Duke O, Mackenzie CD, Guzman JR, Vieira JC, Mendes-Galván J, et al. Eversole and MS Cupp. The effects of long-term community level treatment with ivermectin (Mectizan ®) on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg. 2004; 71: 602-607. DOI: https://doi.org/10.4269/ajtmh.2004.71.602
(47). Rodríguez-Pérez MA, Lugo-Rodríguez L, Lizarazo-Ortega C, Unnasch TR. Entomological and serological assesment of On-chocerca volvulus transmission in the northern Chiapas focus (Mexico). Acta Entomologica Serbica 2006;Sup:51-59.
(48). Hoerauf A, Mand S, Adjei O, Autenrieth B, Fleischer B, Büttner DW. Depletion of Wolbachia endobacteria in Onchocerca vol-vulus by doxycycline and microfilaridermia after ivermectina treatment. Lancet 2001; 357:1415-1416. DOI: https://doi.org/10.1016/S0140-6736(00)04581-5
(49). Edwards G. Ivermectin: does P-glycoprotein play a role in neurotoxicity?. Filaria J 2003;2:S:8 DOI: https://doi.org/10.1186/1475-2883-2-S1-S8
(50). Ottesen EA, Campbell WC. Ivermectin in human medicine. J. Antimicrob Chemother 1994; 34:195-203. DOI: https://doi.org/10.1093/jac/34.2.195
(51). Taylor HR, Muñoz BE, Keyvan BM. Reliability of Detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Ann J Trop Med Hyg 1989;41:467-471. DOI: https://doi.org/10.4269/ajtmh.1989.41.467
(52). Rivas AR, Alvarez G, Villafuerte E, Vázquez E. Correlación en-tre oncocercomas y positividad para microfilarias en oncocerco-sis. Salud Pública Méx 1990;32:658-664.
(53). Bradley JE, Unnasch T. Molecular approaches to the diagnosis of onchocerciasis. Adv Parasitol 1996;37:57-106. DOI: https://doi.org/10.1016/S0065-308X(08)60219-5
(54). Davies JB, Oskam L, Lujan R, Schoone GJ, Kroon CCM, López-Martínez LA, et al. Detection of Onchocerca volvulus DNA in pools of wild-caught Simulium ochraceum by use of the polyme-rase chain reaction. Ann Trop Med Parasitol 1998;92:295-304. DOI: https://doi.org/10.1080/00034983.1998.11813293
(55). Ayong LS, Tume CB, Wembe FE, Simo G, Asonganyi T, Lan-do G, et al. Development and evaluation o fan antigen detection dipstick assay for the diagnosis of human onchocerciasis. Trop Med Int Health 2005;10:228-233. DOI: https://doi.org/10.1111/j.1365-3156.2004.01384.x
(56). Bradley JE, Barbara M, Athogo M, Elson L, Stewart GR, Boussi-nesq M. A cocktail or recombinant Onchocerca volvulus antigens for serologic diagnosis with the potential to predict the endemicity or onchocerciasis infection. Am J Trop Med Hyg 1998;59:877-882. DOI: https://doi.org/10.4269/ajtmh.1998.59.877
(57). Rodríguez-Pérez MA, Danis-Lozano M, Rodríguez-López H, Bradley JE. Application of an enzyme-linked immunosorbent assay to detect antibodies to Onchocerca volvulus on filter-paper blood spots: effect of storage and temperature on antibody decay. Trans R Soc Trop Med Hyg 1999;93:523-524. DOI: https://doi.org/10.1016/S0035-9203(99)90363-2
(58). Weil GJ, Steel C, Liffist F, Li BW, Mearns G, E Lobos and TB Nutman. A rapid format antibody card test for diagnosis of on-chocerciasis. J Infect Dis 2000;182:1-4. DOI: https://doi.org/10.1086/317629
(59). World Health Organization. Certification of Elimination of Human Onchocerciasis: Criteria and Procedures. Geneva: w h o; 2001.
(60). Lindblade KA, Arana B, Zea-Flores G, Rizzo N, Porter CH, Dominguez-Vasquez A, et al. Elimination of Onchocerca vol-Elimination of Onchocerca volvulus transmission in the Santa Rosa focus of Guatemala. Am J Trop Med Hyg 2007; 77:334-341 DOI: https://doi.org/10.4269/ajtmh.2007.77.334
(61). Gonzalez RJ, Cruz-Ortiz N, Rizzo N, Richards J, Zea-Flores G, Domínguez A, et al. Successful Interruption of Transmission of Onchocerca volvulus in the Escuintla-Guatemala Focus, Guate-mala. PLoS Negl Trop Dis 2009: 3:e404. DOI: https://doi.org/10.1371/journal.pntd.0000404
(62). Rodríguez-Pérez MA, Lizarazo-Ortega C, Hassan HK, Domín-guez-Vásquez A, Méndez-Galván J, Lugo-Moreno P, et al. Evi-dence for suppression of Onchocerca volvulus transmission in the Oaxaca focus in Mexico. Am J Trop Med Hyg 2008; 78:147-152. DOI: https://doi.org/10.4269/ajtmh.2008.78.147
(63). Vieira JC, Cooper PJ, Lovato R, Mancero T, Rivera J, Proaño R, et al. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection. b m cMed 2007;23:5-9. DOI: https://doi.org/10.1186/1741-7015-5-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Guadalupe C. Rodríguez C., Cristian Lizarazo O.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
